CD8A and neoplasm: In addition to direct cytotoxic activity, CD4+ T cells engineered with CD8-independent TCRs may secrete soluble factors and cytokines that provide antigen-specific help to enhance the activity and persistence of tumor-specific CD8+ T cells (19).